Pulmonary hypertension - Hemodynamic diagnosis and management

被引：28

作者：

Chatterjee, K

De Marco, T

Alpert, JS

机构：

[1] Univ Calif San Francisco, Chatterjee Ctr Cardiac Res, Sch Med, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Heart Failure & Pulm Hypertens Program, Sch Med, San Francisco, CA 94143 USA

[3] Univ Arizona, Hlth Sci Ctr, Dept Med, Tucson, AZ USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2002年 / 162卷 / 17期

关键词：

D O I：

10.1001/archinte.162.17.1925

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hemodynamic classification of pulmonary hypertension relates to the hemodynamic mechanisms of pulmonary arterial hypertension, such as abnormalities of pulmonary blood flow, pulmonary vascular resistance, and pulmonary venous pressures. The therapeutic approaches can be directed to the hemodynamic mechanisms of pulmonary hypertension.

引用

页码：1925 / 1933

页数：9

共 57 条

[31] Pulmonary hypertension in chronic liver disease
Mandell, MS
Groves, BM
[J]. CLINICS IN CHEST MEDICINE, 1996, 17 (01) : 17 - &
[32] LONG-TERM CLINICAL-RESULTS AFTER VASODILATOR EVALUATION IN PATIENTS WITH PRIMARY (UNEXPLAINED) AND SECONDARY PRECAPILLARY PULMONARY-HYPERTENSION - ACUTE HEMODYNAMIC COMPARISONS AND LONG-TERM SURVIVAL
MCKAY, CR
BRUNDAGE, BH
PORTS, TA
PARMLEY, WW
CHATTERJEE, K
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1989, 22 (03) : 311 - 319
[33] Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
McLaughlin, VV
Genthner, DE
Panella, MM
Rich, S
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05) : 273 - 277
[34] Cor pulmonale
Emil D. Missov
Teresa De Marco
[J]. Current Treatment Options in Cardiovascular Medicine, 2000, 2 (2) : 149 - 158
[35] Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension
Nagaya, N
Uematsu, M
Okano, Y
Satoh, T
Kyotani, S
Sakamaki, F
Nakanishi, N
Miyatake, K
Kunieda, T
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) : 1188 - 1192
[36] Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred
Newman, JH
Wheeler, L
Lane, KB
Loyd, E
Gaddipati, R
Phillips, JA
Loyd, JE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (05) : 319 - 324
[37] EFFECTS OF INTRAVENOUS-INFUSION OF PROSTACYCLIN (PGI2) IN MAN
OGRADY, J
WARRINGTON, S
MOTI, MJ
BUNTING, S
FLOWER, R
FOWLE, ASE
HIGGS, EA
MONCADA, S
[J]. PROSTAGLANDINS, 1980, 19 (02): : 319 - 332
[38] Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation
Okada, K
Bernstein, ML
Zhang, W
Schuster, DP
Botney, MD
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (03) : 939 - 950
[39] Primary pulmonary hypertension
Stuart Rich
[J]. Current Treatment Options in Cardiovascular Medicine, 2000, 2 (2) : 135 - 139
[40] PRIMARY PULMONARY-HYPERTENSION - A NATIONAL PROSPECTIVE-STUDY
RICH, S
DANTZKER, DR
AYRES, SM
BERGOFSKY, EH
BRUNDAGE, BH
DETRE, KM
FISHMAN, AP
GOLDRING, RM
GROVES, BM
KOERNER, SK
LEVY, PC
REID, LM
VREIM, CE
WILLIAMS, GW
[J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) : 216 - 223

← 1 2 3 4 5 6 →